Skip to search formSkip to main contentSkip to account menu

Atrophic Vaginitis

Known as: VAGINITIS ATROPHIC, VAGINITIS ATROPIC, atropic vaginitis 
Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE.
National Institutes of Health

Related topics

Related topics

11 relations

Narrower (2)

Atrophic vulvovaginitisPostmenopausal atrophic vaginitis
Female Reproductive System DisorderIn BloodMicrobiologicalchemically induced

Broader (1)

Vaginitis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis
Atrophic vaginitis (AV) is common in postmenopausal women, but its causes are not well understood. The symptoms, which include… 
Highly Cited
2016
Highly Cited
2016
Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
The purpose of this investigation was to evaluate the impact of the vaginal milieu on the presence of abnormal Pap smears and a… 
Highly Cited
2015
Highly Cited
2015
Atrophic Vaginitis in Breast Cancer Survivors: A Difficult Survivorship Issue
Management of breast cancer includes systematic therapies including chemotherapy and endocrine therapy can lead to a variety of… 
Highly Cited
2012
Highly Cited
2012
Effect of pH on In Vitro Susceptibility of Candida glabrata and Candida albicans to 11 Antifungal Agents and Implications for Clinical Use
ABSTRACT The treatment of vulvovaginal candidiasis (VVC) due to Candida glabrata is challenging, with limited therapeutic options… 
Highly Cited
2011
Highly Cited
2011
The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial
ObjectiveTo compare the effectiveness of the vaginal tablets of hyaluronic acid and estrodiol for the treatment of atrophic… 
Review
2005
Review
2005
Management of post-menopausal vaginal atrophy and atrophic vaginitis.
Review
2003
Review
2003
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
OBJECTIVE The purpose of this study was to review the treatment outcome and safety of topical therapy with boric acid and… 
Highly Cited
2003
Highly Cited
2003
Are women with urogenital atrophy symptomatic?
OBJECTIVE The purpose of this study was to determine the degree of correlation between physical signs of genital atrophy and… 
Review
1992
Review
1992
Pathogenesis and treatment of recurrent vulvovaginal candidiasis.
In contrast to women who experience infrequent episodes of candidal vaginitis, patients with chronic and recurrent candidal… 
Review
1982
Review
1982
The menopause: benefits and risks of estrogen-progestogen replacement therapy.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)